Prospective tumour mutation burden and neoantigen profiling predicts immunotherapy response in metastatic melanoma.
- DOI
- 10.1038/s41698-025-01230-y
- Published
- 2026 Jan 22
- Container
- NPJ precision oncology
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1038/s41698-025-01230-y,
title = {Prospective tumour mutation burden and neoantigen profiling predicts immunotherapy response in metastatic melanoma.},
author = {Mao Y and Gide TN and Maher NG and Vignati D and Boutros A and Cornejo-Páramo P and Potter AJ and Carlino MS and Paver EC and Burke H and Menzies AM and Lo SN and da Silva IP and Scolyer RA and Long GV and Vergara IA and Wilmott JS},
year = {2026},
journal = {NPJ precision oncology},
doi = {10.1038/s41698-025-01230-y},
url = {https://doi.org/10.1038/s41698-025-01230-y}
}RIS
TY - JOUR TI - Prospective tumour mutation burden and neoantigen profiling predicts immunotherapy response in metastatic melanoma. AU - Mao Y AU - Gide TN AU - Maher NG AU - Vignati D AU - Boutros A AU - Cornejo-Páramo P AU - Potter AJ AU - Carlino MS AU - Paver EC AU - Burke H AU - Menzies AM AU - Lo SN AU - da Silva IP AU - Scolyer RA AU - Long GV AU - Vergara IA AU - Wilmott JS PY - 2026 JO - NPJ precision oncology DO - 10.1038/s41698-025-01230-y UR - https://doi.org/10.1038/s41698-025-01230-y ER -
APA
Y, M., TN, G., NG, M., D, V., A, B., P, C., AJ, P., MS, C., EC, P., H, B., AM, M., SN, L., IP, D. S., RA, S., GV, L., IA, V., & JS, W. (2026). Prospective tumour mutation burden and neoantigen profiling predicts immunotherapy response in metastatic melanoma.. NPJ precision oncology. https://doi.org/10.1038/s41698-025-01230-y
Source records
- pubmed · retrieved 2026-09-26T00:45:40.925Z